📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Discovery of new imidazotetrazinones with potential to overcome tumor resistance. (2023)

First Author: Summers HS

Attributed to: University of Nottingham CiC#6 : accelerating translation of novel, early-stage, interdisciplinary, biomedical research funded by UKRI

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejmech.2023.115507

PubMed Identifier: 37262998

Publication URI: http://europepmc.org/abstract/MED/37262998

Type: Journal Article/Review

Volume: 257

Parent Publication: European journal of medicinal chemistry

ISSN: 0223-5234